We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

1 hedge funds and large institutions have $68 invested in Global Blood Therapeutics, Inc. in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $68 → $68 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$68 – – –

GBT Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q1 2024, worth a combined $68 — unchanged from a quarter earlier.

Fund positioning in GBT was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Global Blood Therapeutics, Inc. (GBT) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $68 of Global Blood Therapeutics, Inc. stock for Q1 2024, unchanged quarter-over-quarter.
  • 0 funds opened new Global Blood Therapeutics, Inc. positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.